APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hirudin

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Selected research

Industry Growth & Trends

Global Hirudin Industry Growth and Trends Forecast to 2032

Report ID 17328735011 January 202692 pages

Choose your research edition.

Industry ResearchHirudin Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hirudin Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Hirudin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hirudin Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Hirudin Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.

Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Hirudin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hirudin market size, estimates, and forecasts are presented in terms of sales volume (MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hirudin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hirudin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hirudin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hirudin Market by Company

The Medicines Company

Keyken

Minapharm

Abbott

SALUBRIS

Pfizer, Inc

Teva Pharmaceutical Industries Ltd

DUOPUTAI

Pentapharm

Hirudin Segment by Type

Natural Hirudin

Recombinant Hirudin

Hirudin Segment by Application

Thrombosis Disease

Tumor Disease

Others

Hirudin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hirudin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hirudin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hirudin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hirudin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hirudin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Natural Hirudin Table 2. Major Company of Recombinant Hirudin Table 3. Global Hirudin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hirudin Sales by Type (2021-2026) & (MT) Table 5. Global Hirudin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hirudin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hirudin Sales Market Share in Value by Type (2021-2026) Table 8. Global Hirudin Price by Type (2021-2026) & (USD/Kg) Table 9. Global Hirudin Sales by Type (2027-2032) & (MT) Table 10. Global Hirudin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hirudin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hirudin Sales Market Share in Value by Type (2027-2032) Table 13. Global Hirudin Price by Type (2027-2032) & (USD/Kg) Table 14. North America Hirudin Sales by Type (2021-2026) & (MT) Table 15. North America Hirudin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hirudin Sales by Type (2021-2026) & (MT) Table 17. Europe Hirudin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hirudin Sales by Type (2021-2026) & (MT) Table 19. Asia-Pacific Hirudin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hirudin Sales by Type (2021-2026) & (MT) Table 21. Latin America Hirudin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hirudin Sales by Type (2021-2026) & (MT) Table 23. Middle East and Africa Hirudin Sales by Type (2021-2026) & (US$ Million) Table 24. Hirudin Industry Trends Table 25. Hirudin Industry Drivers Table 26. Hirudin Industry Opportunities and Challenges Table 27. Hirudin Industry Restraints Table 28. Global Hirudin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hirudin Revenue Market Share by Company (2021-2026) Table 30. Global Hirudin Sales by Company (2021-2026) & (MT) Table 31. Global Hirudin Sales Share by Company (2021-2026) Table 32. Global Hirudin Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Hirudin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hirudin Major Company Production Sites and Headquarters Table 35. Global Hirudin Company, Product Type & Application Table 36. Global Hirudin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hirudin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hirudin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hirudin Sales by Region (2021-2026) & (MT) Table 41. Global Hirudin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hirudin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hirudin Sales Market Share in Value by Region (2021-2026) Table 44. Global Hirudin Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Hirudin Sales by Region (2027-2032) & (MT) Table 46. Global Hirudin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hirudin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hirudin Sales Market Share in Value by Region (2027-2032) Table 49. Global Hirudin Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Hirudin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hirudin Sales by Application (2021-2026) & (MT) Table 52. Global Hirudin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hirudin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hirudin Sales Market Share in Value by Application (2021-2026) Table 55. Global Hirudin Price by Application (2021-2026) & (USD/Kg) Table 56. Global Hirudin Sales by Application (2027-2032) & (MT) Table 57. Global Hirudin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hirudin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hirudin Sales Market Share in Value by Application (2027-2032) Table 60. Global Hirudin Price by Application (2027-2032) & (USD/Kg) Table 61. North America Hirudin Sales by Application (2021-2026) & (MT) Table 62. North America Hirudin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hirudin Sales by Application (2021-2026) & (MT) Table 64. Europe Hirudin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hirudin Sales by Application (2021-2026) & (MT) Table 66. Asia-Pacific Hirudin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hirudin Sales by Application (2021-2026) & (MT) Table 68. Latin America Hirudin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hirudin Sales by Application (2021-2026) & (MT) Table 70. Middle East and Africa Hirudin Sales by Application (2021-2026) & (US$ Million) Table 71. The Medicines Company Company Information Table 72. The Medicines Company Business Overview Table 73. The Medicines Company Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. The Medicines Company Hirudin Product Portfolio Table 75. The Medicines Company Recent Development Table 76. Keyken Company Information Table 77. Keyken Business Overview Table 78. Keyken Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Keyken Hirudin Product Portfolio Table 80. Keyken Recent Development Table 81. Minapharm Company Information Table 82. Minapharm Business Overview Table 83. Minapharm Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Minapharm Hirudin Product Portfolio Table 85. Minapharm Recent Development Table 86. Abbott Company Information Table 87. Abbott Business Overview Table 88. Abbott Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Abbott Hirudin Product Portfolio Table 90. Abbott Recent Development Table 91. SALUBRIS Company Information Table 92. SALUBRIS Business Overview Table 93. SALUBRIS Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. SALUBRIS Hirudin Product Portfolio Table 95. SALUBRIS Recent Development Table 96. Pfizer, Inc Company Information Table 97. Pfizer, Inc Business Overview Table 98. Pfizer, Inc Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Pfizer, Inc Hirudin Product Portfolio Table 100. Pfizer, Inc Recent Development Table 101. Teva Pharmaceutical Industries Ltd Company Information Table 102. Teva Pharmaceutical Industries Ltd Business Overview Table 103. Teva Pharmaceutical Industries Ltd Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio Table 105. Teva Pharmaceutical Industries Ltd Recent Development Table 106. DUOPUTAI Company Information Table 107. DUOPUTAI Business Overview Table 108. DUOPUTAI Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. DUOPUTAI Hirudin Product Portfolio Table 110. DUOPUTAI Recent Development Table 111. Pentapharm Company Information Table 112. Pentapharm Business Overview Table 113. Pentapharm Hirudin Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. Pentapharm Hirudin Product Portfolio Table 115. Pentapharm Recent Development Table 116. North America Hirudin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 117. North America Hirudin Sales by Country (2021-2026) & (MT) Table 118. North America Hirudin Sales Market Share by Country (2021-2026) Table 119. North America Hirudin Sales Forecast by Country (2027-2032) & (MT) Table 120. North America Hirudin Sales Market Share Forecast by Country (2027-2032) Table 121. North America Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Hirudin Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Hirudin Market Share by Country (2021-2026) Table 124. North America Hirudin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Hirudin Market Share Forecast by Country (2027-2032) Table 126. Europe Hirudin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 127. Europe Hirudin Sales by Country (2021-2026) & (MT) Table 128. Europe Hirudin Sales Market Share by Country (2021-2026) Table 129. Europe Hirudin Sales Forecast by Country (2027-2032) & (MT) Table 130. Europe Hirudin Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Hirudin Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Hirudin Market Share by Country (2021-2026) Table 134. Europe Hirudin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Hirudin Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Hirudin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Hirudin Sales by Country (2021-2026) & (MT) Table 138. Asia-Pacific Hirudin Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Hirudin Sales Forecast by Country (2027-2032) & (MT) Table 140. Asia-Pacific Hirudin Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Hirudin Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Hirudin Market Share by Country (2021-2026) Table 144. Asia-Pacific Hirudin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Hirudin Market Share Forecast by Country (2027-2032) Table 146. Latin America Hirudin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 147. Latin America Hirudin Sales by Country (2021-2026) & (MT) Table 148. Latin America Hirudin Sales Market Share by Country (2021-2026) Table 149. Latin America Hirudin Sales Forecast by Country (2027-2032) & (MT) Table 150. Latin America Hirudin Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Hirudin Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Hirudin Market Share by Country (2021-2026) Table 154. Latin America Hirudin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Hirudin Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Hirudin Market Size Growth Rate (CAGR) by Country (MT): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Hirudin Sales by Country (2021-2026) & (MT) Table 158. Middle East and Africa Hirudin Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Hirudin Sales Forecast by Country (2027-2032) & (MT) Table 160. Middle East and Africa Hirudin Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Hirudin Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Hirudin Market Share by Country (2021-2026) Table 164. Middle East and Africa Hirudin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Hirudin Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Hirudin Distributors List Table 169. Hirudin Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Hirudin Image Figure 2. Global Hirudin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hirudin Market Size (2021-2032) & (US$ Million) Figure 4. Global Hirudin Sales (2021-2032) & (MT) Figure 5. Natural Hirudin Image Figure 6. Global Natural Hirudin Sales YoY Growth (2021-2032) & (MT) Figure 7. Recombinant Hirudin Image Figure 8. Global Recombinant Hirudin Sales YoY Growth (2021-2032) & (MT) Figure 9. Global Hirudin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hirudin Market Share by Type 2025 VS 2032 Figure 11. North America Hirudin Sales Market Share in Volume by Type in 2025 Figure 12. North America Hirudin Sales Market Share in Value by Type in 2025 Figure 13. Europe Hirudin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hirudin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hirudin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hirudin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hirudin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hirudin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hirudin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hirudin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hirudin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Thrombosis Disease Image Figure 24. Global Thrombosis Disease Sales YoY Growth (2021-2032) & (MT) Figure 25. Tumor Disease Image Figure 26. Global Tumor Disease Sales YoY Growth (2021-2032) & (MT) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (MT) Figure 29. Global Hirudin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Hirudin Market Share by Application 2025 VS 2032 Figure 31. North America Hirudin Sales Market Share in Volume by Application in 2025 Figure 32. North America Hirudin Sales Market Share in Value by Application in 2025 Figure 33. Europe Hirudin Sales Market Share in Volume by Application in 2025 Figure 34. Europe Hirudin Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Hirudin Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Hirudin Sales Market Share in Value by Application in 2025 Figure 37. Latin America Hirudin Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Hirudin Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Hirudin Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Hirudin Sales Market Share in Value by Application in 2025 Figure 41. North America Hirudin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 42. North America Hirudin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Hirudin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Hirudin Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hirudin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 46. Europe Hirudin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Hirudin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Hirudin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hirudin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 50. Asia-Pacific Hirudin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Hirudin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Hirudin Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hirudin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 54. Latin America Hirudin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Hirudin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Hirudin Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hirudin Sales by Country: 2021 VS 2025 VS 2032 (MT) Figure 58. Middle East and Africa Hirudin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Hirudin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Hirudin Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Hirudin Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Hirudin Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Natural Hirudin
  • Recombinant Hirudin
Applications
  • Thrombosis Disease
  • Tumor Disease
  • Others
Companies covered
  • The Medicines Company
  • Keyken
  • Minapharm
  • Abbott
  • SALUBRIS
  • Pfizer, Inc
  • Teva Pharmaceutical Industries Ltd
  • DUOPUTAI
  • Pentapharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hirudin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hirudin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hirudin Market by Type
  6. 1.3.1 Natural Hirudin
  7. 1.3.2 Recombinant Hirudin
  8. 1.4 Global Hirudin Market Size by Type
  9. 1.4.1 Global Hirudin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hirudin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hirudin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hirudin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hirudin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hirudin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hirudin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hirudin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hirudin Industry Trends
  2. 2.2 Hirudin Industry Drivers
  3. 2.3 Hirudin Industry Opportunities and Challenges
  4. 2.4 Hirudin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hirudin Revenue (2021-2026)
  2. 3.2 Global Top Players by Hirudin Sales (2021-2026)
  3. 3.3 Global Top Players by Hirudin Price (2021-2026)
  4. 3.4 Global Hirudin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hirudin Major Company Production Sites & Headquarters
  6. 3.6 Global Hirudin Company, Product Type & Application
  7. 3.7 Global Hirudin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hirudin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hirudin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hirudin Tier 1, Tier 2, and Tier 3
4 Hirudin Regional Status and Outlook
  1. 4.1 Global Hirudin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hirudin Historic Market Size by Region
  3. 4.2.1 Global Hirudin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hirudin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hirudin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hirudin Forecasted Market Size by Region
  7. 4.3.1 Global Hirudin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hirudin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hirudin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hirudin by Application
  1. 5.1 Hirudin Market by Application
  2. 5.1.1 Thrombosis Disease
  3. 5.1.2 Tumor Disease
  4. 5.1.3 Others
  5. 5.2 Global Hirudin Market Size by Application
  6. 5.2.1 Global Hirudin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Hirudin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Hirudin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Hirudin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Hirudin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Hirudin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Hirudin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Hirudin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 The Medicines Company
  2. 6.1.1 The Medicines Company Company Information
  3. 6.1.2 The Medicines Company Business Overview
  4. 6.1.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 The Medicines Company Hirudin Product Portfolio
  6. 6.1.5 The Medicines Company Recent Developments
  7. 6.2 Keyken
  8. 6.2.1 Keyken Company Information
  9. 6.2.2 Keyken Business Overview
  10. 6.2.3 Keyken Hirudin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Keyken Hirudin Product Portfolio
  12. 6.2.5 Keyken Recent Developments
  13. 6.3 Minapharm
  14. 6.3.1 Minapharm Company Information
  15. 6.3.2 Minapharm Business Overview
  16. 6.3.3 Minapharm Hirudin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Minapharm Hirudin Product Portfolio
  18. 6.3.5 Minapharm Recent Developments
  19. 6.4 Abbott
  20. 6.4.1 Abbott Company Information
  21. 6.4.2 Abbott Business Overview
  22. 6.4.3 Abbott Hirudin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Abbott Hirudin Product Portfolio
  24. 6.4.5 Abbott Recent Developments
  25. 6.5 SALUBRIS
  26. 6.5.1 SALUBRIS Company Information
  27. 6.5.2 SALUBRIS Business Overview
  28. 6.5.3 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SALUBRIS Hirudin Product Portfolio
  30. 6.5.5 SALUBRIS Recent Developments
  31. 6.6 Pfizer, Inc
  32. 6.6.1 Pfizer, Inc Company Information
  33. 6.6.2 Pfizer, Inc Business Overview
  34. 6.6.3 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer, Inc Hirudin Product Portfolio
  36. 6.6.5 Pfizer, Inc Recent Developments
  37. 6.7 Teva Pharmaceutical Industries Ltd
  38. 6.7.1 Teva Pharmaceutical Industries Ltd Company Information
  39. 6.7.2 Teva Pharmaceutical Industries Ltd Business Overview
  40. 6.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Pharmaceutical Industries Ltd Hirudin Product Portfolio
  42. 6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments
  43. 6.8 DUOPUTAI
  44. 6.8.1 DUOPUTAI Company Information
  45. 6.8.2 DUOPUTAI Business Overview
  46. 6.8.3 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 DUOPUTAI Hirudin Product Portfolio
  48. 6.8.5 DUOPUTAI Recent Developments
  49. 6.9 Pentapharm
  50. 6.9.1 Pentapharm Company Information
  51. 6.9.2 Pentapharm Business Overview
  52. 6.9.3 Pentapharm Hirudin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pentapharm Hirudin Product Portfolio
  54. 6.9.5 Pentapharm Recent Developments
7 North America by Country
  1. 7.1 North America Hirudin Sales by Country
  2. 7.1.1 North America Hirudin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hirudin Sales by Country (2021-2026)
  4. 7.1.3 North America Hirudin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hirudin Market Size by Country
  6. 7.2.1 North America Hirudin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hirudin Market Size by Country (2021-2026)
  8. 7.2.3 North America Hirudin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hirudin Sales by Country
  2. 8.1.1 Europe Hirudin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hirudin Sales by Country (2021-2026)
  4. 8.1.3 Europe Hirudin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hirudin Market Size by Country
  6. 8.2.1 Europe Hirudin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hirudin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hirudin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hirudin Sales by Country
  2. 9.1.1 Asia-Pacific Hirudin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hirudin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hirudin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hirudin Market Size by Country
  6. 9.2.1 Asia-Pacific Hirudin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hirudin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hirudin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hirudin Sales by Country
  2. 10.1.1 South America Hirudin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hirudin Sales by Country (2021-2026)
  4. 10.1.3 South America Hirudin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hirudin Market Size by Country
  6. 10.2.1 South America Hirudin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hirudin Market Size by Country (2021-2026)
  8. 10.2.3 South America Hirudin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hirudin Sales by Country
  2. 11.1.1 Middle East and Africa Hirudin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hirudin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hirudin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hirudin Market Size by Country
  6. 11.2.1 Middle East and Africa Hirudin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hirudin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hirudin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hirudin Value Chain Analysis
  2. 12.1.1 Hirudin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hirudin Production Mode & Process
  7. 12.2 Hirudin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hirudin Distributors
  10. 12.2.3 Hirudin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst